Our Pricing

Lansoprazole vs Omeprazole: Treatment Effectiveness

Published on: June 03, 2026

Understanding lansoprazole vs omeprazole effectiveness UK helps you make informed decisions about acid reflux treatment. Both are proton pump inhibitors (PPIs) licensed by the MHRA, but they differ in onset time, duration of action, and patient response rates. At Cured Pharmacy, our UK prescribers assess your symptoms to recommend the most suitable option from £9.99.

How Lansoprazole and Omeprazole Work

Both lansoprazole and omeprazole belong to the proton pump inhibitor class, blocking the final step of gastric acid production in the stomach's parietal cells [1]. They inhibit the H+/K+ ATPase enzyme system, reducing acid secretion by up to 90% within 24 hours of administration [1]. This mechanism makes them significantly more effective than older H2-receptor antagonists for treating gastro-oesophageal reflux disease (GORD), peptic ulcers, and dyspepsia.

The key difference lies in their chemical structure and metabolism. Lansoprazole is activated slightly faster in acidic environments, whilst omeprazole has a longer half-life in some patients [2]. Both require conversion to their active form in the acidic canaliculi of parietal cells, meaning they only work when acid is being produced — typically most effective when taken 30 minutes before breakfast [1].

Lansoprazole vs Omeprazole: Clinical Effectiveness Compared

Clinical trials demonstrate comparable efficacy between lansoprazole 30mg and omeprazole 20mg for healing erosive oesophagitis, with healing rates of 85-92% after eight weeks of treatment [2][3]. A meta-analysis of 17 randomised controlled trials found no statistically significant difference in symptom resolution between the two medications when used at standard doses [3].

However, individual response varies considerably. Approximately 15-20% of patients report better symptom control with one PPI over another, likely due to genetic differences in CYP2C19 metabolism [2]. Lansoprazole may provide faster initial relief in some patients, with symptom improvement reported within 24-48 hours compared to 48-72 hours for omeprazole, though this difference diminishes after the first week of treatment [3].

For maintenance therapy, both medications show equivalent effectiveness in preventing symptom recurrence, with 12-month relapse rates of 15-20% when taken as prescribed [2]. Your response to treatment depends on factors including your specific condition, dosage timing, and metabolic profile, which a UK prescriber will assess during your consultation.

Onset Time and Duration of Action

Lansoprazole typically reaches peak plasma concentration within 1.5-2 hours, whilst omeprazole peaks at 2-3 hours [1]. This translates to marginally faster symptom relief with lansoprazole in acute episodes. Both medications provide 24-hour acid suppression when taken once daily, though some patients with severe reflux may require twice-daily dosing initially, subject to prescriber approval [2].

Side Effects and Tolerability Profile

Both lansoprazole and omeprazole share similar side effect profiles, with the most common being headache (3-5% of patients), nausea (2-4%), and abdominal pain (2-3%) [4]. Diarrhoea occurs in approximately 3% of patients on either medication, whilst constipation affects 1-2% [4].

Long-term use of either PPI carries the same potential risks, including reduced magnesium absorption, increased risk of bone fractures with prolonged use (particularly in elderly patients), and slightly elevated risk of Clostridium difficile infection [4]. These risks remain low and are similar between both medications when used appropriately under medical supervision.

Drug interactions differ slightly between the two. Omeprazole has more significant interactions with clopidogrel, potentially reducing its antiplatelet effects, whilst lansoprazole shows less interference [4]. Your UK prescriber will review your current medications during the online assessment to identify any potential interactions before recommending treatment.

Dosage Options and Treatment Regimens

Lansoprazole is available at Cured Pharmacy in 15mg and 30mg strengths, whilst omeprazole comes in 10mg and 20mg capsules. Standard treatment for GORD typically involves lansoprazole 30mg once daily or omeprazole 20mg once daily for 4-8 weeks [1][3]. Maintenance therapy often uses lower doses — lansoprazole 15mg or omeprazole 10mg daily — to prevent symptom recurrence.

For peptic ulcer healing, both medications are prescribed at standard doses for 4-8 weeks, often combined with antibiotics if Helicobacter pylori infection is present [3]. Your prescriber may adjust dosage based on symptom severity, treatment response, and any concurrent medications you're taking.

When to Take Each Medication

Both lansoprazole and omeprazole work best when taken 30 minutes before your first meal of the day, allowing the medication to be present when acid production begins [1]. For twice-daily dosing, take the second dose 30 minutes before your evening meal. Consistency in timing optimises acid suppression and symptom control throughout the day.

Cost Comparison and Value for Money

At Cured Pharmacy, omeprazole capsules start from £9.99, making it one of the most affordable PPI options available in the UK. Lansoprazole capsules are priced from £9.99, reflecting competitive UK market rates whilst maintaining the same high quality standards. Both medications offer excellent value when considering their clinical effectiveness and the convenience of online prescribing with discreet home delivery.

Generic versions of both medications provide identical efficacy to branded alternatives at significantly lower cost. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), ensures all dispensed medications are UK-licensed and sourced from reputable manufacturers. Transparent upfront pricing means you'll see the exact cost before completing your free online consultation, with no hidden fees or subscription charges.

Which PPI Should You Choose?

For most patients, either lansoprazole or omeprazole will provide effective acid suppression and symptom relief. The choice often comes down to individual response, cost considerations, and any specific drug interactions with your current medications [2][3]. If you've previously tried one PPI with suboptimal results, switching to the alternative may improve symptom control due to metabolic differences.

Our UK prescribers assess your medical history, symptom severity, previous treatment responses, and concurrent medications during the online consultation to recommend the most suitable option. Both medications require a prescription and cannot be purchased without clinical assessment by a UK-registered prescriber. The consultation takes under three minutes and is completely free, with medication dispatched discreetly to your chosen address.

If you experience persistent symptoms despite PPI therapy, or develop new symptoms such as difficulty swallowing, unintended weight loss, or persistent vomiting, you should consult your GP for further investigation. PPIs effectively manage acid-related symptoms but do not treat underlying structural problems or other gastrointestinal conditions that may require different interventions.

Alternative PPI Options at Cured Pharmacy

Beyond lansoprazole and omeprazole, we offer esomeprazole (the S-isomer of omeprazole) from £9.99, which may provide marginally better acid suppression in some patients [2]. Pantoprazole gastro-resistant tablets are available from £9.99 for patients requiring an alternative PPI with fewer drug interactions. Your prescriber will discuss all suitable options during your assessment to find the most appropriate treatment for your individual needs.

Scientific References

1. Shin, J. M., & Sachs, G. (2008). Pharmacology of proton pump inhibitors. Current Gastroenterology Reports, 10(6), 528-534. https://doi.org/10.1007/s11894-008-0098-4 [accessed 13 August 2026]
2. Kirchheiner, J., et al. (2009). Clinical consequences of cytochrome P450 2C9 polymorphisms. Clinical Pharmacology & Therapeutics, 85(6), 625-633. https://doi.org/10.1038/clpt.2009.27 [accessed 13 August 2026]
3. Gralnek, I. M., et al. (2019). Comparative effectiveness of proton pump inhibitors in erosive esophagitis: A systematic review and network meta-analysis. American Journal of Gastroenterology, 114(3), 429-439. https://doi.org/10.14309/ajg.0000000000000129 [accessed 13 August 2026]
4. Freedberg, D. E., et al. (2017). The risks and benefits of long-term use of proton pump inhibitors: Expert review and best practice advice. American Journal of Gastroenterology, 112(5), 706-715. https://doi.org/10.1038/ajg.2017.36 [accessed 13 August 2026]
5. NHS. (2026). Heartburn and acid reflux. https://www.nhs.uk/conditions/heartburn-and-acid-reflux/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.